Skip to main content
. 2022 Jan 21;6(1):ytab478. doi: 10.1093/ehjcr/ytab478

Figure 3.

Figure 3

Myocarditis from anti-PD-L1 treatment with a very high-sensitivity troponin I level (12 122 ng/L at time of cardiovascular magnetic resonance). (A) T2-weighted SPAIR, (B) T2 mapping, (C) native T1 mapping, (D, E) phase sensitive inversion recovery late gadolinium enhancement imaging, and (F) cine steady state free precession. Focal mid-ventricular inferior/inferoseptal myocardial oedema (block arrows), high signal intensity focal subepicardial late gadolinium enhancement (arrowheads), and mild pericardial effusion (*) are demonstrated.